My First deep DD Post: A massively undervalued SAAS with US and UK regulatory tailwinds and a CEO that takes no salary

Hi all - a first time post for me here. This was personal DD, written up. The company in I have in mind is AudioEye (AEYE) which is listed on the NASDAQ, and the current setup offers one of the most asymmetric risk-reward profiles I’ve seen in the small-cap software space. Despite just pre-announcing its **fortieth consecutive quarter of record revenue** and posting substantial adjusted EBITDA, the stock is trading at a valuation that is completely disconnected from its fundamentals. AudioEye is a software platform that makes websites accessible to people with disabilities to comply with laws like the ADA and EAA. It uses AI to automatically find and fix accessibility barriers like missing image descriptions, keyboard traps, and poor color contrast in real-time. Their AI automatically repairs these navigation obstacles for screen readers, while human experts manually fix complex structural issues the software can't. It ensures websites meet WCAG/ADA legal standards to protect businesses from lawsuits and make sites usable for people with disabilities. These laws will apply to almost everyone in the USA, and in Europe to companies with revenues over EUR 2m or 10 employees. # A Regulatory Super-Cycle The market seems to be pricing this like a stagnant micro-cap, ignoring the fact that we are approaching a massive regulatory catalyst. The DOJ’s Title II deadline hits on April 24, 2026, effectively mandating that state and local governments ensure their digital content is ADA-compliant. This shifts AudioEye's product from a discretionary "nice-to-have" to a legal necessity for nearly 90,000 local government entities, including school districts and public agencies, creating a demand floor that hasn't been fully priced in. AudioEye is already a dominant leader in this niche with over 110,000 customers already on the platform. The timing here is key because we are less than three months away from this federal deadline, yet the stock is trading significantly below analyst price targets, which my personal analysis suggest over 100% upside from current levels. When you combine the domestic urgency of Title II with the ongoing enforcement of the European Accessibility Act, you have a regulatory super-cycle converging with a business that is already hitting nearly $40M in ARR and expanding margins. With a Total Addressable Market (TAM) now estimated at over $3 billion, the company is barely scratching the surface of its potential. # I believe the market is wrong The stock has seen recent price dumping primarily due to corporate sales contracts timing issues resulting in lower than guidance results, which isn't a reflection of the core business health. Like I said, it has **40 consecutive months of revenue growth.** In reality, the company is at a major inflection point in terms of profitability. They have successfully retired old R&D and legacy costs, which significantly improved margins going forward as they finally pay off those heavy development years. They also retired some old customers that involved manual low margin work in the last quarter. Resulting in missing guidance, triggering a sell-off that was not really rooted in fundamental business reasons at all. In fact, growth will speed up now with the EU and DOJ legislation in place. # Key Financial & Management Highlights: * Management & Insider Confidence: There is massive conviction from the top. T**he CEO is not taking a salary for two years**, ultimate alignment with shareholders. Furthermore, we’ve seen insider buying at prices over 30% above the current level, and insiders now own 30% of the company. * Strong Capital Allocation: The company is putting its money where its mouth is, having completed $3.6M worth of share buybacks over the first 3 quarters of 2025, with another likely $1.5m in Q4. * Predictable, High-Margin Revenue: AudioEye is an 80% amargin SaaS business with 90% recurring revenue on longer contracts, providing incredible stability. * Growth Outlook: Management isn't slowing down; they expect 20-40% revenue growth in 2026. * Cash Flow Machine: The business is finally profitable and reaching an inflection point, generating $8M in annual Free Cash Flow (FCF). * **In essence, after years of taking losses due to the heavy R&D costs, they now have a built platform, and you can buy into a FCF generating machine that is still priced with uncertainty I don't believe its operations actually have.** * Valuation Gap: Despite these fundamentals, the stock is trading at a lowly P/S of 2.8, representing a steep discount compared to other high-growth SaaS peers that lack this kind of regulatory protection. It is rare to find a SaaS company with this kind of recurring revenue stability and government-mandated tailwinds trading at such a compressed multiple. This feels like a window to front-run the inevitable volume as compliance deadlines force capital allocation into the sector. As always, do your own due diligence.